In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3889-13-2, name is 5-Nitro-2,3-dihydro-1,3-benzoxazol-2-one, introducing its new discovery. name: 5-Nitro-2,3-dihydro-1,3-benzoxazol-2-one
Alpha2C adrenoreceptor agonists
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as alpha2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the alpha2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3889-13-2, and how the biochemistry of the body works.name: 5-Nitro-2,3-dihydro-1,3-benzoxazol-2-one
Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem